Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alkaline Phosphatase for Ischemia Reperfusion Injury to Prevent Delayed Graft Function
2021-006767-14Phase 2Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2022
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in ischemia-reperfusion injury (IRI) and delayed graft function (DGF) comparing bovine Rescue Alkaline Phosphatase with Placebo (2 arms). Primary endpoint: Duration of delayed graft function. Started Aug 2022; status: active.
02
Drugs
bovine rescue alkaline phosphatase
03
Conditions
ischemia-reperfusion injury (IRI)delayed graft function (DGF)
Beyond the preview
Go deeper on 2021-006767-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006767-14.